Evidence map›Paper›PMID 34769677›Full record

SynthesisInternational journal of environmental research and public health2021

Evidence and Therapeutic Perspectives in the Relationship between the Oral Microbiome and Alzheimer's Disease: A Systematic Review.

Yoann Maitre, Rachid Mahalli, Pierre Micheneau, Alexis Delpierre, Gilles Amador, Frédéric Denis

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 5 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 5 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Oral Health as a Risk Factor for Alzheimer Disease.The journal of prevention of Alzheimer's disease · 2024
    Pooled it
  5. Pooled it
  6. Review
  7. Review
  8. Review
  9. Can Beetroot (Nutrients · 2025
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Oral Microbiome Stamp in Alzheimer's Disease.Pathogens (Basel, Switzerland) · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yoann MaitreEmergency Department, Montpellier University Hospital, 34090 Montpellier, France.
Rachid MahalliDepartment of Odontology, Tours University Hospital, 37000 Tours, France.
Pierre MicheneauDepartment of Odontology, Tours University Hospital, 37000 Tours, France.
Alexis DelpierreDepartment of Odontology, Tours University Hospital, 37000 Tours, France.
Gilles AmadorFaculty of Dentistry, Nantes University, 44000 Nantes, France.
Frédéric DenisDepartment of Odontology, Tours University Hospital, 37000 Tours, France.
Université de Tours · FRNantes Université · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review aims to clarify the nature of the link between Alzheimer's disease and the oral microbiome on an epidemiological and pathophysiological level, as well as to highlight new therapeutic perspectives that contribute to the management of this disease. We performed a systematic review, following the Preferred Reporting Items for Systematic Reviews checklist, from January 2000 to July 2021. The terms "plaque," "saliva," and "mouth" were associated with the search term "oral diseases" and used in combination with the Boolean operator "AND"/"OR". We included experimental or clinical studies and excluded conferences, abstracts, reviews, and editorials. A total of 27 articles were selected. Evidence for the impact of the oral microbiome on the pathophysiological and immunoinflammatory mechanisms of Alzheimer's disease is accumulating. The impact of the oral microbiome on the development of AD opens the door to complementary therapies such as phototherapy and/or the use of prebiotic compounds and probiotic strains for global or targeted modulation of the oral microbiome in order to have a favourable influence on the evolution of this pathology in the future.

Indexed as

Alzheimer DiseaseMicrobiotaMouth DiseasesHumansSalivaAlzheimer’s diseasemental disordersoral microbiomeoral microbiota

Identifiers

PMID34769677
PMCPMC8583399
OpenAlexW3209004694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.